As the COVID-19 pandemic continues to disrupt our lives and health care system on a historic scale, it is worth considering whether it has also revolutionized drug development and pricing in a profound way. COVID-19 vaccines were produced in record time using a novel approach: Drug makers committed to specific prices before receiving regulatory approvals. This development may have significant implications for California policymakers considering how to make prescription drugs more affordable. Read more here.
(Source: Sarah K. Emond; CA Healthcare Foundation; 12/20/20)